BIOGEN IDEC - Restructuring of Tysabri Collaboration with ELAN - A Good Strategic Move! - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-03-14 08:49:03
Biogen Idec (BIIB) has acquired full rights to Tysabri from Elan for an upfront payment of $3.25b and a double-digit tiered royalty structure. Integrating this in our model the net positive impact to NPV/s of Tysabri is $9.4 (current NPV/s of Tysabri: $40
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.